Aryzta, a global food business based in Switzerland and listed on the SIX, has entered into an underwritten agreement with three banks for a new €500 million revolving credit facility. The facility which is expected to
Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20